HealthEcon’s Managing Director, Dr. Stephan Ruckdäschel, has extensive experience working in market-access-related functions within the pharmaceutical industry. Since 2005 he’s working with HealthEcon in various projects for different clients. Such he provides 19 years of experience in development and implementation of tailored solutions for the pharma­ceutical clients covering a wide area of heterogeneous questions and topics.

Dr. Ruckdäschel has compiled and lead a multitude of HTAs, value and reimbursement dossiers. He participated in several advisory boards (e.g. cancer, dermatology) to support identification, assessment and phrasing value propositions for authorities, payers and KOLs.

Dr. Ruckdäschel studied political economics. After his PhD in 2000, he joined Pfizer in Outcomes Research and Disease Management, where he established a private public partnership between the AOK and Pfizer / Eisai on a care management program in dementia.

Dr. Stephan Ruckdäschel